Javier Dı́ez

29.0k total citations · 8 hit papers
407 papers, 19.8k citations indexed

About

Javier Dı́ez is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Javier Dı́ez has authored 407 papers receiving a total of 19.8k indexed citations (citations by other indexed papers that have themselves been cited), including 237 papers in Cardiology and Cardiovascular Medicine, 99 papers in Molecular Biology and 56 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Javier Dı́ez's work include Cardiovascular Function and Risk Factors (77 papers), Cardiac Fibrosis and Remodeling (71 papers) and Heart Failure Treatment and Management (35 papers). Javier Dı́ez is often cited by papers focused on Cardiovascular Function and Risk Factors (77 papers), Cardiac Fibrosis and Remodeling (71 papers) and Heart Failure Treatment and Management (35 papers). Javier Dı́ez collaborates with scholars based in Spain, United States and United Kingdom. Javier Dı́ez's co-authors include Arantxa González, Begoña López, Ramón Querejeta, Susana Ravassa, Ana Fortuño, Gorka San José, Guillermo Zalba, Mariano Larman, Javier Beaumont and María Antonia Fortuño and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Javier Dı́ez

394 papers receiving 19.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

2011 653 citations Javier Dı́ez et al. profile →
Myocardial remodeling after infarction: the role of myofibroblasts

2009 581 citations Javier Dı́ez et al. profile →
Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients

2002 500 citations Javier Dı́ez, Ramón Querejeta et al. profile →
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy

2010 484 citations Carolyn Y. Ho, Begoña López et al. New England Journal of Medicine profile →
Myocardial Interstitial Fibrosis in Heart Failure

2018 467 citations Arantxa González, Javier Dı́ez et al. profile →
Myocardial Fibrosis: Biomedical Research from Bench to Bedside

2017 302 citations Mariann Gyöngyösi, Johannes Winkler et al. European Journal of Heart Failure profile →
Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis

2018 232 citations Begoña López, Arantxa González et al. profile →
Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches

2021 215 citations Begoña López, Susana Ravassa et al. profile →

Peers

Countries citing papers authored by Javier Dı́ez

Since Specialization

Citations

This map shows the geographic impact of Javier Dı́ez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Dı́ez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Dı́ez more than expected).

Fields of papers citing papers by Javier Dı́ez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Dı́ez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Dı́ez. The network helps show where Javier Dı́ez may publish in the future.

Co-authorship network of co-authors of Javier Dı́ez

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Dı́ez. A scholar is included among the top collaborators of Javier Dı́ez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Dı́ez. Javier Dı́ez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cardiovascular risk assessment: Missing albuminuria contributing to gender inequality 2025 ·Nefrología (English Edition) ·Patricia de Sequera, (unknown), Borja Quiroga, (unknown), (unknown), (unknown), (unknown), Javier Dı́ez, Alberto Ortíz	1
2	Possible Role of Gut Microbiota Alterations in Myocardial Fibrosis and Burden of Heart Failure in Hypertensive Heart Disease 2024 ·Hypertension ·Bertram Pitt, Javier Dı́ez	3
3	The kidney–skeletal muscle–heart axis in chronic kidney disease: implications for myokines 2024 ·Nephrology Dialysis Transplantation ·Borja Quiroga, Javier Dı́ez	2
4	Practical approaches to building up a cardiorenal clinic 2022 ·Clinical Kidney Journal ·Rafael de la Espriella, Marta Cobo Marcos, Claudio Ronco, Debasish Banerjee, Miguel González, José Luis Górriz, Borja Quiroga, María José Soler, Javier Dı́ez, Julio Núñez	10
5	Long-Term Prognostic Impact of Estimated Glomerular Filtration Rate on Admission in Patients Hospitalized for Acute Heart Failure 2022 ·Cardiorenal Medicine ·Rafael de la Espriella, Jorge Navarro, Anna Mollar, Luis D’Marco, Patricia Palau, Gema Miñana, Pau Llàcer, Enrique Santas, (unknown), Miguel González, José Luis Górriz, Pau Codina, Javier Dı́ez, Antoni Bayés‐Genís, Julio Núñez	5
6	A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy 2022 ·Cancers ·(unknown), Marta Santisteban, Josep Lupón, José Manuel Aramendía, (unknown), Ana Santaballa, (unknown), Pilar Sepúlveda, Germán Cediel, Begoña López, José M. López-Picazo, Manuel Mazo, Gregorio Rábago, Juán José Gavira, Ignacio García‐Bolao, Javier Dı́ez, Arantxa González, Antoni Bayés‐Genís, Susana Ravassa	4
7	Growing Heart Failure Burden of Hypertensive Heart Disease: A Call to Action 2022 ·Hypertension ·Javier Dı́ez, Javed Butler	41
8	Myocardial Fibrosis: Biomedical Research from Bench to Bedside breakdown → 2017 ·European Journal of Heart Failure ·Mariann Gyöngyösi, Johannes Winkler, Isbaal Ramos, Quoc‐Tuan Do, Hüseyin Firat, Kenneth McDonald, Arantxa González, Thomas Thum, Javier Dı́ez, Frédéric Jaisser, Anne Pizard, Faı̈ez Zannad	302
9	Rationale of the FIBROTARGETS Study Designed to Identify Novel Biomarkers of Myocardial Fibrosis 2017 ·ESC Heart Failure ·João Pedro Ferreira, Jean‐Loup Machu, Nicolas Girerd, Frédéric Jaisser, Thomas Thum, Javed Butler, Arantxa González, Javier Dı́ez, Stéphane Heymans, Kenneth McDonald, Mariann Gyöngyösi, (unknown), Patrick Rossignol, Anne Pizard, Faı̈ez Zannad	18
10	Galectin-3 and Histological, Molecular and Biochemical Aspects of Myocardial Fibrosis in Heart Failure of Hypertensive Origin 2015 ·European Journal of Heart Failure ·Begoña López, Arantxa González, Ramón Querejeta, Elena Zubillaga, Mariano Larman, Javier Dı́ez	45
11	Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy breakdown → 2010 ·New England Journal of Medicine ·Carolyn Y. Ho, Begoña López, Otávio R. Coelho‐Filho, Neal K. Lakdawala, Allison L. Cirino, Petr Jarolı́m, Raymond Y. Kwong, Arantxa González, Steven D. Colan, Jonathan G. Seidman, Javier Dı́ez, Christine E. Seidman	484
12	Prevalence of Left Ventricular Diastolic Dysfunction in a General Population 2009 ·Circulation Heart Failure ·Tatiana Kuznetsova, Lieven Herbots, Begoña López, Yu Jin, Tom Richart, Lutgarde Thijs, Arantxa González, Marie‐Christine Herregods, Robert Fagard, Javier Dı́ez, Jan A. Staessen	249
13	Losartan Metabolite EXP3179 Blocks NADPH Oxidase-Mediated Superoxide Production by Inhibiting Protein Kinase C 2009 ·Hypertension ·Ana Fortuño, (unknown), (unknown), José Hermida, Jacinto López‐Sagaseta, Óscar Beloqui, Javier Dı́ez, Guillermo Zalba	51
14	Asociación de marcadores inflamatorios y aterosclerosis subclínica en relación con la edad en sujetos sin enfermedad cardiovascular 2008 ·Medicina Clínica ·José A. Páramo, Josune Orbe, Óscar Beloqui, Inmaculada Colina, Alberto Benito, José Antonio Rodríguez, Javier Dı́ez	5
15	Dispensación de antibióticos sin receta en Bizkaia en 2004 2006 ·(unknown), (unknown), (unknown), (unknown), Javier Dı́ez	1
16	Guía de la Sociedad Española de Nefrología sobre riñón y enfermedad cardiovascular.: Versión Abreviada 2006 ·Nefrología ·Raúl Marin, (unknown), Manuel Gorostidi, Aleix Cases, Javier Dı́ez, (unknown), Francisco Fernández-Vega, R. Palomar, Emilio Rodrigo, Isabel Martínez, J. Segura	8
17	Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension 2004 ·Cardiovascular Research ·Carmen Roncal, Josune Orbe, José Antonio Rodríguez, (unknown), Óscar Beloqui, Javier Dı́ez, José A. Páramo	15
18	Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases 2003 ·Journal of Physiology and Biochemistry ·Ana Fortuño, Amaia Rodrı́guez, Javier Gómez‐Ambrosi, Gema Frühbeck, Javier Dı́ez	102
19	Implicaciones de la leptina en la fisiopatología de las enfermedades cardiovasculares 2000 ·Clínica e Investigación en Arteriosclerosis ·Gema Frühbeck, Javier Salvador, Javier Dı́ez	3
20	The use of IgE immunoblotting as a diagnostic tool in Anisakis simplex allergy 1997 ·Journal of Allergy and Clinical Immunology ·Miquel García, Ignacio Moneo, M. Audícana, Miguel Á. del Pozo, David G. Muñoz, Eduardo Fernández, Javier Dı́ez, (unknown), Ignacio J. Ansotegui, (unknown)	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact